icon
icon
icon
icon
🏷️$300 Off
🏷️$300 Off

News /

Articles /

Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year

Marcus LeeMonday, Feb 24, 2025 2:57 pm ET
1min read


Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, has been named to Fortune's World's Most Admired Companies list for the 11th consecutive year. The company was recognized for its strong performance in the "Health Care: Pharmacy and Other Services" industry, ranking number three overall and scoring high marks in quality of management, long-term investment, product and service quality, social responsibility, and people management.

Quest Diagnostics' consistent recognition as one of the World's Most Admired Companies can be attributed to several factors, including its commitment to innovation, community responsibility, and talent management. The company has invested heavily in research and development, staying at the forefront of diagnostic technologies and expanding its service offerings. Additionally, Quest Diagnostics has demonstrated a strong commitment to social responsibility, providing free HIV testing and counseling services in underserved communities and supporting research on various diseases, including cancer and infectious diseases.



Quest Diagnostics' market share and competitive position within the healthcare and diagnostic testing sectors have remained strong over the years. The company's market share in the Medical Laboratories Industry was 36.53% in Q3 2024, and its market share in the Healthcare Sector was 9.97% in the same quarter. Quest Diagnostics has maintained its leadership position by employing strategies such as innovation, partnerships, expansion, acquisitions, and a focus on quality and customer service.

In conclusion, Quest Diagnostics' consistent recognition as one of the World's Most Admired Companies is a testament to the company's commitment to innovation, community responsibility, and talent management. The company's strong market share and competitive position within the healthcare and diagnostic testing sectors demonstrate its ability to stay ahead of the competition and maintain its reputation as a leader in the industry. As Quest Diagnostics continues to invest in research and development, expand its service offerings, and demonstrate its commitment to social responsibility, it is well-positioned to maintain its status as one of the World's Most Admired Companies for years to come.
Comments

Add a public comment...
Post
User avatar and name identifying the post author
Far_Sentence_5036
02/24
Holding $DGX for long term. Diagnostic tech is evolving, and they're leading the charge. Solid play for growth.
0
Reply
User avatar and name identifying the post author
Mojojojo3030
02/24
Fortune's list ain't easy, Quest earned it 💪
0
Reply
User avatar and name identifying the post author
pellosanto
02/24
$DGX strong fundamentals, holding for long-term gains
0
Reply
User avatar and name identifying the post author
Antinetdotcom
02/24
11th year on that Fortune list? DGX is setting the bar high. Quality management must be on point. 📈
0
Reply
User avatar and name identifying the post author
bottomline77
02/24
Community involvement is key, Quest gets it right
0
Reply
User avatar and name identifying the post author
Dependent-Teacher595
02/24
Quest Diagnostics crushing it with innovation and social responsibility. Free HIV testing? That's some next-level corporate citizenship. 💪
0
Reply
User avatar and name identifying the post author
CertifiedWwDuby
02/24
@Dependent-Teacher595 Makes sense
0
Reply
User avatar and name identifying the post author
Ok_Secret4642
02/24
Partnership and expansion strategy seems strong. They're not just sitting on their market share. Aggressive and smart moves.
0
Reply
User avatar and name identifying the post author
Big-Decision-1458
02/24
@Ok_Secret4642 Agreed, Quest's moves look solid.
0
Reply
User avatar and name identifying the post author
Shinoskay9
02/24
Medical labs industry leader, Quest's tech is fire
0
Reply
User avatar and name identifying the post author
MasterDeath
02/24
@Shinoskay9 👍
0
Reply
User avatar and name identifying the post author
MarshallGrover
02/24
Holding $DGX for the long haul. Their commitment to R&D and talent management gives me peace of mind for retirement funds.
0
Reply
User avatar and name identifying the post author
smarglebloppitydo
02/24
Quest Diagnostics crushing it in healthcare, no cap.
0
Reply
User avatar and name identifying the post author
smooth_and_rough
02/24
@smarglebloppitydo What do you think about their growth potential?
0
Reply
User avatar and name identifying the post author
lem_lel
02/24
Fortune list is cool, but let's see how they handle the competition. Healthcare is cutthroat. Keep an eye on them.
0
Reply
User avatar and name identifying the post author
Luka77GOATic
02/24
Quest's innovation game is strong. They're not just riding the wave, they're surfing it with a surfboard made of acquisitions and partnerships.
0
Reply
User avatar and name identifying the post author
ttforum
02/24
36.53% market share is no joke. DGX is the big dog in medical labs. Anyone else think they're a safe bet?
0
Reply
User avatar and name identifying the post author
caollero
02/24
Free HIV testing? That's not just corporate social responsibility; that's being a real-life hero. Kudos, Quest.
0
Reply
User avatar and name identifying the post author
big_nate410
02/24
11 years running on Fortune's list? That's not just consistency; that's a gold-standard work ethic right there.
0
Reply
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
You Can Understand News Better with AI.
Whats the News impact on stock market?
Its impact is
fork
logo
AInvest
Aime Coplilot
Invest Smarter With AI Power.
Open App